Aleafia Health Inc
TSX:AH
Intrinsic Value
Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. [ Read More ]
The intrinsic value of one
AH
stock under the Base Case scenario is
0.29
CAD.
Compared to the current market price of 0.02 CAD,
Aleafia Health Inc
is
Undervalued by 93%.
Aleafia Health Inc's market capitalization is 4m CAD.
AH stock price is 0.02 CAD.
AH stock price (0.02 CAD) is 93% less than its Intrinsic Value (0.29 CAD).
AH.
AH's Revenue has dropped by 1% over the past 12 months.
AH has positive Gross Profit for the last twelve months.
AH's long-term liabilties (69m CAD) exceed its long-term assets (60m CAD).
AH's Revenue has been growing by 13% per year for the last 3 years.
AH's short-term liabilties (31m CAD) exceed its short-term assets (26m CAD).
AH's ROE (Return on Equity) has significantly increased in the last 3 years from -93% to 948%.
AH's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -84% to -35%, and is approaching profitability.
AH has negative Operating Income for the last twelve months.
AH has negative Net Income for the last twelve months.
AH's ROE (Return on Equity) for the past 12 months is very high and is equal to 948%.
AH's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -35%.
AH has negative Free Cash Flow for the last twelve months.
AH has positive Net Debt. This means that the company has more debt (33m CAD) than cash and short-term investments (535k CAD).
AH has negative three-year average ROE (Return on Equity): -43%. The company is not efficient at transforming stockholders' equity into net income.
AH has negative three-year average ROIC (Return on Invested Capital): -39%. The company is not efficient at using invested capital to generate operating income.
AH's D/E (Debt to Equity) is very low and is equal to -3.72.
AH's Altman Z-Score is very low and is equal to -12.65.
AH doesn't generate enough operating income (-18m CAD) to safely cover interest payments on its debt (2m CAD).
Fundamental Analysis
Aleafia Health Inc
Balance Sheet Decomposition
Aleafia Health Inc
| Current Assets | 25.8m |
| Cash & Short-Term Investments | 535k |
| Receivables | 4.3m |
| Other Current Assets | 21m |
| Non-Current Assets | 34.1m |
| Long-Term Investments | 2.4m |
| PP&E | 21.7m |
| Other Non-Current Assets | 10m |
| Current Liabilities | 31.3m |
| Accounts Payable | 9.2m |
| Other Current Liabilities | 22m |
| Non-Current Liabilities | 37.6m |
| Long-Term Debt | 33.2m |
| Other Non-Current Liabilities | 4.4m |
Earnings Waterfall
Aleafia Health Inc
|
Revenue
|
42.8m
CAD
|
|
Cost of Revenue
|
-36.8m
CAD
|
|
Gross Profit
|
6m
CAD
|
|
Operating Expenses
|
-24.3m
CAD
|
|
Operating Income
|
-18.3m
CAD
|
|
Other Expenses
|
-16.3m
CAD
|
|
Net Income
|
-34.6m
CAD
|
Free Cash Flow Analysis
Aleafia Health Inc
AH Profitability Score
Profitability Due Diligence
Aleafia Health Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
Aleafia Health Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
AH Solvency Score
Solvency Due Diligence
Aleafia Health Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Score
Aleafia Health Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AH Price Targets Summary
Aleafia Health Inc
Shareholder Return
AH Price
Aleafia Health Inc
| Average Annual Return | -51.91% |
| Standard Deviation of Annual Returns | 25.28% |
| Max Drawdown | -99% |
| Market Capitalization | 4m CAD |
| Shares Outstanding | 201 632 599 |
| Percentage of Shares Shorted | 0.59% |
Company Profile
Aleafia Health Inc
Country
Industry
Market Cap
Dividend Yield
Description
Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. The company is headquartered in Concord, Ontario. The company went IPO on 2011-07-29. The firm is engaged in offering cannabis health and wellness services and products in Canada. The firm owns and operates a virtual network of medical cannabis clinics staffed by physicians and nurse practitioners. The firm owns three licensed cannabis production facilities and operates distribution center all in the province of Ontario, including outdoor cultivation facility. The firm produces a diverse portfolio of cannabis derivative products including oils, capsules, edibles, sublingual strips, and vapes, for sale in Canada in the medical and adult-use markets. Its subsidiaries include Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and Emblem Realty Limited.
You don't have any saved screeners yet
